Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: Clin Immunol. 2011 Jan 14;139(1):75–84. doi: 10.1016/j.clim.2011.01.001

Table 2.

Common Features of HIES patients by mutation region.

Feature DNA region mutations N=35 SH2 region mutations N=30 P value

HIES Score median (IQR+) 73 (60, 82) 79 (65, 86) 0.193$

IgE Median (IQR) 11,500 (7240, 21800) 10,100 (5602, 17640) 0.330$

Highest absolute eosinophil count median (IQR) 936 (810, 1420) 845 (524, 971) 0.154$

>3 pneumonias 23(66%) 18(60%) 0.965^

Pneumatoceles or bronchiectasis 24 (69%) 23 (77%) 0.582*

>4 boils 27 (77%) 20 (67%) 0.479^

Candidiasis
 None 4 (11.8%) 6 (20.7%) 0.57^
 Oral/vaginal 13 (38.2%) 9 (31.0%)
 Fingernail 17 (50.0%) 14 (48.3%)

Newborn Rash 29 (83%) 22(76%) 0.544*

Moderate-Severe Eczema 34 (97%) 27 (90%) 0.302^

>1 retained primary teeth 27(77%) 19 (63%) 0.750^

>10 degree scoliosis 18 (51%) 21(70%) 0.282^

>2 fractures 13 (37%) 15 (54%) 0.112^

Hyperextensibility 23 (66%) 20(77%) 0.404*

Facial Changes 28 (80%) 25 (86%) 0.741*

Hyperintensities on brain MRI 16 (62%) 15 (56%) 0.974^

Arnold Chiari Malformations 13 (42%) 9 (35%) 0.598*

Coronary Artery abnormalities 12(63%) 8(50%) 0.506*
*

P-values determined by Fisher’s exact test.

$

P-values determined by Wilcoxon test.

^

P-values determined by Cochran-Armitage Trend test

+

IQR = Interquartile Range

Percentages are based on the number of non-missing values